Endobronchial Tubes Market Introduction
An endobronchial tube is a medical device that is used for intubation during a thoracic surgery and other medical conditions to ventilate either side of the lung. Endobronchial tubes comprise two small lumen endotracheal tubes of different lengths that are attached together. The small tube is placed at trachea and longer one is placed at either side of the lung. There are several medical indications that require only either side of the lung to be ventilated. Endobronchial tubes are primarily indicated for separation of right side of the lung from left side in order to prevent the bleeding, pus, and other spillage from affected one to non-affected one. The other conditions where endobronchial tubes are most commonly used are aortic aneurysm surgery, pneumonectomy, or loboctomy, and anesthesia procedures. The Carlens and the Robertshaw tubes are most commonly used endobronchial tubes in health care facilities.
Global Endobronchial Tubes Market: Competitive Landscape
The global endobronchial tubes market is highly fragmented, with a large number of domestic players holding majority share in respective regions. Mergers & acquisition, new product development, and commercialization are some of the key trends observed in global endobronchial tubes market.
To Know the Segments Analyzed in the Endobronchial Tubes Market Report, Ask for a Brochure here
Medtronic is a diversified medical device company engaged in the manufacture of a range of medical devices and technologies. The company develops and markets products and therapies in the areas of cardiac rhythm disorders, cardiovascular diseases, neurological disorders, spinal conditions, and diabetes. The company operates its entire business through four functional business divisions: Cardiac & Vascular Group, Minimally Invasive Therapies Group, Restorative Therapies Group, and Diabetes Group.
Teleflex Incorporated is a global provider of medical technologies that fulfill the clinical needs of patients and health care providers. The company has a diverse portfolio with solutions in the fields of interventional access, vascular access, cardiology, anesthesia, surgical care, respiratory care, and emergency services. In 2015, the company combined its respiratory and urology business divisions.
Smiths Medical is a subsidiary of Smiths Group Plc. The company is focused on clinical research and manufactures medical devices that are used in diagnostic, therapeutic, and surgical procedures. The company’s core focus areas are in surgical, safety, vital care, and medication. Its portfolio includes assisted reproduction devices, diabetes solutions, infusion devices, drainage systems, interventional imaging systems, pain management products, patient monitoring equipment, respiratory systems, and patients warming devices.
Ambu A/S is a Denmark-based company. It is one of the leading players in medical device industry that develops, manufactures, and commercializes various products across the globe. The company markets its products in areas of airway management, anesthesia, ENT specialty, patient monitoring, and diagnostics devices. In the field of airway management, the company markets a wide variety of products such as bronchoscopes, video laryngoscopes, endobronchial tubes with integrated camera, endobronchial blockers, laryngeal masks, and resuscitators.
To Know More about TMRs Unique Offerings for Endobronchial Tubes Market, Request a Custom Report here
Global Endobronchial Tubes Market: Dynamics
High Prevalence and Incidence Rates of Chronic Pulmonary Disorders to Drive Market
The global endobronchial tubes market is primarily driven by high prevalence of chronic pulmonary disorders such as lung cancer, chronic obstructive pulmonary disorders, and lung infection. According to the World Cancer Research Fund, around 2 million cases of lung cancer were reported across the globe in 2018. According to the American Cancer Society, of the total number of cancer patients diagnosed every year in the U.S., around 13% had lung cancer. According to the World Health Organization (WHO), in 2016, more than 251 million people across the globe were affected by chronic obstructive pulmonary disorder (COPD). Moreover, rise in demand for minimally invasive cardiac surgeries and rapidly growing thoracic hemorrhage cases across the globe are estimated to contribute to the growth of global endobronchial tubes market during the forecast period. Hence, high prevalence of lung cancer and chronic obstructive pulmonary disorders is likely to boost the global endobronchial tubes market during the forecast period.
On the other side, the availability and growing adoption of alternative single lung ventilation techniques and products such as single lumen tracheal tubes and endobronchial blockers are likely to restrain the endobronchial tubes market during the forecast period.
Global Endobronchial Tubes Market: Segmentation
In terms of product, the global endobronchial tubes market can be classified into:
- Single Lumen Endobronchial Tube
- Double Lumen Endobronchial Tube
Based on application, the global endobronchial tubes market can be categorized into:
- Lung Cancer
- Chronic Obstructive Pulmonary Disorder
- Thoracic Surgery
In terms of end-user, the global endobronchial tubes market can be divided into:
- Ambulatory Surgery Centers
- Specialty Clinics
This study by TMR is all-encompassing framework of the dynamics of the market. It mainly comprises critical assessment of consumers' or customers' journeys, current and emerging avenues, and strategic framework to enable CXOs take effective decisions.
Our key underpinning is the 4-Quadrant Framework EIRS that offers detailed visualization of four elements:
- Customer Experience Maps
- Insights and Tools based on data-driven research
- Actionable Results to meet all the business priorities
- Strategic Frameworks to boost the growth journey
The study strives to evaluate the current and future growth prospects, untapped avenues, factors shaping their revenue potential, and demand and consumption patterns in the global market by breaking it into region-wise assessment.
The following regional segments are covered comprehensively:
- North America
- Asia Pacific
- Latin America
- The Middle East and Africa
The EIRS quadrant framework in the report sums up our wide spectrum of data-driven research and advisory for CXOs to help them make better decisions for their businesses and stay as leaders.
Below is a snapshot of these quadrants.
1. Customer Experience Map
The study offers an in-depth assessment of various customers’ journeys pertinent to the market and its segments. It offers various customer impressions about the products and service use. The analysis takes a closer look at their pain points and fears across various customer touchpoints. The consultation and business intelligence solutions will help interested stakeholders, including CXOs, define customer experience maps tailored to their needs. This will help them aim at boosting customer engagement with their brands.
2. Insights and Tools
The various insights in the study are based on elaborate cycles of primary and secondary research the analysts engage with during the course of research. The analysts and expert advisors at TMR adopt industry-wide, quantitative customer insights tools and market projection methodologies to arrive at results, which makes them reliable. The study not just offers estimations and projections, but also an uncluttered evaluation of these figures on the market dynamics. These insights merge data-driven research framework with qualitative consultations for business owners, CXOs, policy makers, and investors. The insights will also help their customers overcome their fears.
3. Actionable Results
The findings presented in this study by TMR are an indispensable guide for meeting all business priorities, including mission-critical ones. The results when implemented have shown tangible benefits to business stakeholders and industry entities to boost their performance. The results are tailored to fit the individual strategic framework. The study also illustrates some of the recent case studies on solving various problems by companies they faced in their consolidation journey.
4. Strategic Frameworks
The study equips businesses and anyone interested in the market to frame broad strategic frameworks. This has become more important than ever, given the current uncertainty due to COVID-19. The study deliberates on consultations to overcome various such past disruptions and foresees new ones to boost the preparedness. The frameworks help businesses plan their strategic alignments for recovery from such disruptive trends. Further, analysts at TMR helps you break down the complex scenario and bring resiliency in uncertain times.
The report sheds light on various aspects and answers pertinent questions on the market. Some of the important ones are:
1. What can be the best investment choices for venturing into new product and service lines?
2. What value propositions should businesses aim at while making new research and development funding?
3. Which regulations will be most helpful for stakeholders to boost their supply chain network?
4. Which regions might see the demand maturing in certain segments in near future?
5. What are the some of the best cost optimization strategies with vendors that some well-entrenched players have gained success with?
6. Which are the key perspectives that the C-suite are leveraging to move businesses to new growth trajectory?
7. Which government regulations might challenge the status of key regional markets?
8. How will the emerging political and economic scenario affect opportunities in key growth areas?
9. What are some of the value-grab opportunities in various segments?
10. What will be the barrier to entry for new players in the market?
Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.